These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22327486)

  • 21. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness.
    Campione E; Paternò EJ; Diluvio L; Orlandi A; Bianchi L; Chimenti S
    J Dermatolog Treat; 2009; 20(1):10-3. PubMed ID: 18651299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
    Wolf IH; Cerroni L; Kodama K; Kerl H
    Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children.
    Arican O
    Pediatr Int; 2006 Aug; 48(4):403-5. PubMed ID: 16911087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of oral dysplasia with 5% imiquimod cream: short communication.
    Mullins R; Ansell M; Laverick S
    Br J Oral Maxillofac Surg; 2016 Nov; 54(9):1028-1029. PubMed ID: 27178528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
    Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
    Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
    J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
    Gebauer K; Shumack S; Cowen PS
    Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
    Barba AR; Kapoor S; Berman B
    Dermatol Online J; 2001 Feb; 7(1):20. PubMed ID: 11328641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream.
    Micali M; Nasca MR; Musumeci ML
    Int J Tissue React; 2005; 27(3):111-4. PubMed ID: 16372477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of imiquimod 5% cream (Aldara® in the treatment of aural plaque in horses: a pilot open-label clinical trial.
    Torres SM; Malone ED; White SD; Koch SN; Watson JL
    Vet Dermatol; 2010 Oct; 21(5):503-9. PubMed ID: 20500494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.